Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  NY-ESO-1 peptide vaccine
Find trials that include:  Any drugs shown
Results 1-3 of 3 for your search:
Start Over
Gene and Vaccine Therapy in Treating Patients With Advanced Malignancies
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 16 and over
Trial IDs: 12-000153, NCI-2012-01548, NCT01697527
Nivolumab, Vaccine Therapy, and Ipilimumab in Treating Patients with Stage III or Stage IV Melanoma That Has Been Removed by Surgery
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 16 and over
Trial IDs: MCC-15651, NCI-2011-00737, CDR0000682183, NCI-P8316, P-8316, 8316, NCT01176474
NY-ESO-1 Vaccine in Combination With Ipilimumab in Patients With Unresectable or Metastatic Melanoma
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: LUD2012-004, NCI-2013-01366, NCT01810016
Start Over